# Medidata Solutions

> Medidata Solutions is a New York-based, cloud software company that runs the digital plumbing of modern clinical research. Its flagship Rave EDC pioneered electronic data capture in clinical trials, and today its unified platform spans data capture, patient engagement, AI analytics, imaging, and trial operations. A Dassault Systèmes company since 2019, Medidata powers trials for most of the world's largest pharmaceutical companies and has supported the development of a large share of newly approved drugs and medical devices.

- **Founded:** 1999
- **Headquarters:** New York, United States
- **Founders:** Tarek Sherif (Co-Founder and former Chairman & CEO), Glen de Vries (Co-Founder and former Vice Chairman (1972-2021)), Edward Ikeguchi (Co-Founder)
- **Team size:** ~2,900 employees
- **Products:** Medidata Rave EDC, Medidata Clinical Cloud / Unified Platform, Medidata AI, Patient Cloud (eCOA / eConsent / Sensor Cloud), Medidata Rave Imaging
- **Notable:** Pioneered electronic data capture in clinical trials with Rave EDC (2001)., Reported helping advance 80% of FDA novel drug launches in 2025 and powering design of over 50% of new medical devices., More than a decade of applied AI across 500+ clinical studies.

## Products & services

- **Medidata Rave EDC** — The flagship electronic data capture and clinical data management system, introduced in 2001, that replaced paper-based trial data collection.
- **Medidata Clinical Cloud / Unified Platform** — A cloud platform unifying study design, data capture, operations, patient engagement, and analytics across the trial lifecycle.
- **Medidata AI** — AI and real-world analytics suite (built on the SHYFT and Acorn AI heritage) including synthetic control arms, predictive analytics, and trial insights.
- **Patient Cloud (eCOA / eConsent / Sensor Cloud)** — Patient-facing tools for electronic clinical outcome assessments, electronic consent, and remote/decentralized data capture.
- **Medidata Rave Imaging** — AI-powered medical imaging management for clinical trials, with automated PHI redaction and faster image processing.
- **Dot (AI Companion)** — An AI companion introduced in 2026 that integrates Study, Data, and Patient experiences across the clinical journey.
- **Medidata AI Study Build** — Generative-AI tooling that configures Rave EDC and eCOA from the study protocol to compress study start-up time.

## Achievements

- Pioneered electronic data capture in clinical trials with Rave EDC (2001).
- Reported helping advance 80% of FDA novel drug launches in 2025 and powering design of over 50% of new medical devices.
- More than a decade of applied AI across 500+ clinical studies.
- Named #11 on the Fortune Future 50 list (2017).
- Acquired by Dassault Systèmes for $5.8 billion in 2019, one of the largest life-sciences software deals.

## Latest updates

- **2026-05** — Unveiled next-gen AI imaging solution at ASCO 2026, delivering 32% faster PHI redaction for clinical trial images.
- **2026-03** — At NEXT New York, introduced AI companions led by 'Dot' and 'orchestrated intelligence' across study, data, and patient experiences.
- **2026-02** — Launched Medidata AI Study Build, using generative AI to configure Rave EDC and eCOA from the study protocol.
- **2025** — Reported supporting 80% of FDA novel drug launches and 120+ AI-supported studies beginning in 2025; Anthony Costello named CEO.

## Links

- Website: https://www.medidata.com
- LinkedIn: https://www.linkedin.com/company/medidata-solutions
- Twitter/X: https://x.com/medidata
- YouTube: https://www.youtube.com/channel/UCDQCfBLE3q5teYucTY1ZNUw
- Instagram: https://www.instagram.com/medidata.solutions/
- Facebook: https://www.facebook.com/MedidataSolutions/

---

Profile page: https://yespress.io/medidata-solutions
Published by YesPress — https://yespress.io
Last updated: 2026-06-02